Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
The fact that 70% of CROs/Pharma are unable to reap full value from their Salesforce Investment makes them face challenges with patient recruitment, collaboration across sites and patient retention. If you have invested in Salesforce for clinical trials or have plans of doing so, we can help you maximize Salesforce value with our Cloud Capabilities.
We provide delivery models focused on outcomes, use automation first approach, democratize the adoption of Salesforce and leverage industry tools & accelerators to fast-track implementation. Our solutions include:
Watch the video here to get more insights on our cloud capabilities for clinical trial management.